ASND
Price
$126.52
Change
+$2.19 (+1.76%)
Updated
Nov 11, 03:28 PM (EDT)
3 days until earnings call
NRSN
Price
$1.33
Change
+$0.04 (+3.10%)
Updated
Nov 11, 04:00 PM (EDT)
16 days until earnings call
Ad is loading...

ASND vs NRSN

Header iconASND vs NRSN Comparison
Open Charts ASND vs NRSNBanner chart's image
Ascendis Pharma A/S
Price$126.52
Change+$2.19 (+1.76%)
Volume$500
CapitalizationN/A
NeuroSense Therapeutics
Price$1.33
Change+$0.04 (+3.10%)
Volume$7.75K
CapitalizationN/A
View a ticker or compare two or three
ASND vs NRSN Comparison Chart
Loading...
ASND
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NRSN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
ASND vs. NRSN commentary
Nov 11, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASND is a Buy and NRSN is a StrongBuy.

COMPARISON
Comparison
Nov 11, 2024
Stock price -- (ASND: $124.33 vs. NRSN: $1.29)
Brand notoriety: ASND and NRSN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ASND: 67% vs. NRSN: 13%
Market capitalization -- ASND: $7.43B vs. NRSN: $25.55M
ASND [@Biotechnology] is valued at $7.43B. NRSN’s [@Biotechnology] market capitalization is $25.55M. The market cap for tickers in the [@Biotechnology] industry ranges from $467.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.79B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ASND’s FA Score shows that 0 FA rating(s) are green whileNRSN’s FA Score has 0 green FA rating(s).

  • ASND’s FA Score: 0 green, 5 red.
  • NRSN’s FA Score: 0 green, 5 red.
According to our system of comparison, NRSN is a better buy in the long-term than ASND.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ASND’s TA Score shows that 4 TA indicator(s) are bullish while NRSN’s TA Score has 4 bullish TA indicator(s).

  • ASND’s TA Score: 4 bullish, 5 bearish.
  • NRSN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, NRSN is a better buy in the short-term than ASND.

Price Growth

ASND (@Biotechnology) experienced а -0.76% price change this week, while NRSN (@Biotechnology) price change was +1.58% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.45%. For the same industry, the average monthly price growth was +13.33%, and the average quarterly price growth was +9.34%.

Reported Earning Dates

ASND is expected to report earnings on Apr 02, 2025.

NRSN is expected to report earnings on Mar 19, 2025.

Industries' Descriptions

@Biotechnology (+3.45% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ASND($7.43B) has a higher market cap than NRSN($25.6M). NRSN YTD gains are higher at: 64.331 vs. ASND (-1.286).
ASNDNRSNASND / NRSN
Capitalization7.43B25.6M29,023%
EBITDA-362.83MN/A-
Gain YTD-1.28664.331-2%
P/E RatioN/AN/A-
Revenue329MN/A-
Total Cash320MN/A-
Total Debt669MN/A-
FUNDAMENTALS RATINGS
ASND: Fundamental Ratings
ASND
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
PROFIT vs RISK RATING
1..100
76
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
56
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
48

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ASNDNRSN
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
74%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
75%
Bullish Trend 4 days ago
77%
MACD
ODDS (%)
Bullish Trend 4 days ago
69%
Bullish Trend 4 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
74%
Bullish Trend 4 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
80%
Bullish Trend 4 days ago
85%
Advances
ODDS (%)
Bullish Trend 6 days ago
71%
Bullish Trend 5 days ago
88%
Declines
ODDS (%)
Bearish Trend 4 days ago
77%
Bearish Trend 13 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
69%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
83%
N/A
View a ticker or compare two or three
Ad is loading...
ASND
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NRSN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PSC55.460.42
+0.76%
Principal US Small Cap ETF
DECZ38.400.13
+0.35%
TrueShares Structured Outcome Dec ETF
SDVY38.600.08
+0.21%
First Trust SMID Cp Rising Div Achv ETF
CPII19.600.02
+0.09%
Ionic Inflation Protection ETF
WDIV65.36-0.24
-0.37%
SPDR® S&P Global Dividend ETF

ASND and

Correlation & Price change

A.I.dvisor indicates that over the last year, ASND has been loosely correlated with NUVL. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ASND jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ASND
1D Price
Change %
ASND100%
-1.75%
NUVL - ASND
41%
Loosely correlated
+1.41%
ORMP - ASND
37%
Loosely correlated
-2.94%
AMRN - ASND
35%
Loosely correlated
-0.12%
AXON - ASND
34%
Loosely correlated
+28.68%
CASI - ASND
33%
Poorly correlated
-2.48%
More

NRSN and

Correlation & Price change

A.I.dvisor tells us that NRSN and SLRX have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NRSN and SLRX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRSN
1D Price
Change %
NRSN100%
N/A
SLRX - NRSN
32%
Poorly correlated
+2.04%
CTMX - NRSN
31%
Poorly correlated
+9.00%
ASND - NRSN
26%
Poorly correlated
-1.75%
CRBP - NRSN
24%
Poorly correlated
+1.40%
ELVAF - NRSN
24%
Poorly correlated
-5.26%
More